Innovative OTC Stock Valuation

Do you want to know what the current value of Innovative Medtech is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Innovative Medtech, is its stock price multiplied by the total number of shares outstanding, calculating Innovative Medtech's enterprise value requires a different approach. It uses Innovative Medtech's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Innovative Medtech regular Real Value cannot be determined due to lack of data. The prevalent price of Innovative Medtech is $0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model calculates the value of Innovative Medtech from evaluating the firm fundamentals such as Number of Employees of 1, shares outstanding of 163.56 K, and Current Valuation of 968.93 K as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Innovative Valuation 

 
Refresh
Innovative Medtech Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Innovative Medtech's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Innovative Medtech Total Value Analysis

Innovative Medtech is currently anticipated to have valuation of 968.93 K with market capitalization of 81.78 K, debt of 744.96 K, and cash on hands of 608. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innovative Medtech fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
968.93 K81.78 K744.96 K608

Innovative Medtech Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Innovative implies not a very effective usage of assets in October.

Innovative Medtech Profitability Analysis

Net Loss for the year was (365.34 K).
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Tools for Innovative OTC Stock

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go